283 related articles for article (PubMed ID: 11732398)
1. [Drug manufacturer on the savings package of Ulla Schmidt. "Grip in the moth box of planned economics"].
Schmidt K
MMW Fortschr Med; 2001 Nov; 143(44):52. PubMed ID: 11732398
[No Abstract] [Full Text] [Related]
2. Pharmaceuticals and medical devices: cost savings. End-of-year issue brief.
Health Policy Tracking Service, A Service of Thomson Reuters/West
Issue Brief Health Policy Track Serv; 2011 Jan; ():1-21. PubMed ID: 21374837
[No Abstract] [Full Text] [Related]
3. Pharmaceuticals and medical devices: cost savings.
; Steiner DJ
Issue Brief Health Policy Track Serv; 2012 Jan; ():1-37. PubMed ID: 22403843
[No Abstract] [Full Text] [Related]
4. [Schröder intervenes in drug savings package. Sparing for the industry, more restrictions for us physicians?].
Jentsch P
MMW Fortschr Med; 2001 Nov; 143(44):50-1. PubMed ID: 11732397
[No Abstract] [Full Text] [Related]
5. Pharmaceuticals and medical devices: cost savings.
Steiner DJ
Issue Brief Health Policy Track Serv; 2013 Dec; ():1-32. PubMed ID: 24482891
[No Abstract] [Full Text] [Related]
6. Pharmaceuticals and medical devices: cost savings. End-of-year issue brief.
Chaps NA
Issue Brief Health Policy Track Serv; 2010 Jan; ():1-18. PubMed ID: 20213921
[No Abstract] [Full Text] [Related]
7. Pharmaceuticals and medical devices: cost savings.
; Steiner DJ
Issue Brief Health Policy Track Serv; 2014 Dec; ():1-32. PubMed ID: 25771553
[No Abstract] [Full Text] [Related]
8. In that case: a pharmaceutical company that makes generic versions of commonly used drugs has produced a generic of a proprietary drug widely prescribed in a particular service. Response.
Grice S
N Z Bioeth J; 2003 Oct; 4(3):22-4. PubMed ID: 15597479
[No Abstract] [Full Text] [Related]
9. [Parallel import of drugs for better and for worse].
Krabbe U
Ugeskr Laeger; 2004 Feb; 166(7):611. PubMed ID: 15005051
[No Abstract] [Full Text] [Related]
10. In that case: a pharmaceutical company that makes generic versions of commonly used drugs has produced a generic of a proprietary drug widely prescribed in a particular service. Response.
Menkes DB; Woodall AA
N Z Bioeth J; 2003 Oct; 4(3):22, 24-5. PubMed ID: 15597480
[No Abstract] [Full Text] [Related]
11. [New cost saving legislation for drugs. National health insurance carriers do not want to believe Ulla Schmidt}].
MMW Fortschr Med; 2006 Feb; 148(5):45. PubMed ID: 16518939
[No Abstract] [Full Text] [Related]
12. In that case: a pharmaceutical company that makes generic versions of commonly used drugs has produced a generic of a proprietary drug widely prescribed in a particular service. Response.
Woolner D
N Z Bioeth J; 2003 Oct; 4(3):22, 25-6. PubMed ID: 15597481
[No Abstract] [Full Text] [Related]
13. In that case: a pharmaceutical company that makes generic versions of commonly used drugs has produced a generic of a proprietary drug widely prescribed in a particular service. Response.
Adams J
N Z Bioeth J; 2003 Oct; 4(3):22-3. PubMed ID: 15597478
[No Abstract] [Full Text] [Related]
14. [Medical problems and risks of switching drugs according to legal requirements of drug discount contracts in Germany].
Pruszydlo MG; Quinzler R; Kaltschmidt J; Haefeli WE
Dtsch Med Wochenschr; 2008 Jul; 133(27):1423-8. PubMed ID: 18592450
[TBL] [Abstract][Full Text] [Related]
15. Drug costs threaten patent protection.
Cimons M
Nat Med; 2003 Jan; 9(1):9. PubMed ID: 12514706
[No Abstract] [Full Text] [Related]
16. Pharmaceuticals and medical devices: cost savings. End-of-year issue brief.
Chaps NA
Issue Brief Health Policy Track Serv; 2008 Jan; ():1-27. PubMed ID: 18345555
[No Abstract] [Full Text] [Related]
17. [The reference price system for drugs saves 5 billions crowns in Germany].
Lind J
Lakartidningen; 1992 Dec; 89(50):4334-7. PubMed ID: 1469959
[No Abstract] [Full Text] [Related]
18. [Follow up studies as a condition for drug subsidizing].
Kieler H; Ekbom A; Fored M; Montgomery SM; Wettermark B
Lakartidningen; 2009 May 13-19; 106(20):1406-7. PubMed ID: 19585842
[No Abstract] [Full Text] [Related]
19. Pharmaceuticals and Medical Devices: Cost Savings.
Steiner DJ;
Issue Brief Health Policy Track Serv; 2018 Dec; 2018():1-31. PubMed ID: 30695849
[No Abstract] [Full Text] [Related]
20. Protect pharmaceutical innovation.
Musselwhite LW; Andrews J
Science; 2010 Jun; 328(5984):1354; author reply 1354-5. PubMed ID: 20538934
[No Abstract] [Full Text] [Related]
[Next] [New Search]
